Epiterna uses a unique high-throughput drug screening platform to develop therapies to slow ageing. The startup has raised €10m from Prima Materia, the investment firm founded by Spotify founder Daniel Ek and early Spotify backer Shakil Khan.
Epiterna uses a unique high-throughput drug screening platform to develop therapies to slow ageing. The startup has raised €10m from Prima Materia, the investment firm founded by Spotify founder Daniel Ek and early Spotify backer Shakil Khan.